Epigenetics and chromatin remodeling in adult cardiomyopathy

Journal of Pathology

Volumn 231, Issue 2, 2013, Pages 147-157

  Mahmoud, Salma Awad ^a   Poizat, Coralie ^a,b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

adult cardiomyopathy; cardiac hypertrophy; chromatin remodeling; epigenetics; gene regulation; Histone modification

Indexed keywords

ADENOSINE TRIPHOSPHATE; BAF60C PROTEIN; BARRIER TO AUTOINTEGRATION FACTOR; BRG1 PROTEIN; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE H3; HISTONE H3 S10; HISTONE H3 S28; HISTONE H3K27; HISTONE H3K36; HISTONE H3K4; HISTONE H3K79; HISTONE H3K9; PROTAMINE KINASE; PROTEIN SWI; TRANSCRIPTION FACTOR SNF; UNCLASSIFIED DRUG;

CARDIOMYOPATHY; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN STRUCTURE; DEACETYLATION; DEMETHYLATION; DISEASE COURSE; DNA METHYLATION; ENZYME PHOSPHORYLATION; EPIGENETICS; GENE CONTROL; GENETIC ASSOCIATION; GENOME; HEART VENTRICLE HYPERTROPHY; HISTONE ACETYLATION; HISTONE PHOSPHORYLATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ADULT CARDIOMYOPATHY; CARDIAC HYPERTROPHY; CHROMATIN REMODELING; EPIGENETICS; GENE REGULATION; HISTONE MODIFICATION;

ANIMALS; CARDIOMYOPATHIES; CHROMATIN ASSEMBLY AND DISASSEMBLY; EPIGENESIS, GENETIC; HUMANS;

EID: 84883857540     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4234     Document Type: Review

References (108)

1. Kornberg RD, Lorch Y,. Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 1999; 98: 285-294.
2. Zhou VW, Goren A, Bernstein BE,. Charting histone modifications and the functional organization of mammalian genomes. Nat Rev Genet 2011; 12: 7-18.
3. Berger SL,. The complex language of chromatin regulation during transcription. Nature 2007; 447: 407-412.
4. Vignali M, Hassan AH, Neely KE, et al., ATP-dependent chromatin-remodeling complexes. Mol Cell Biol 2000; 20: 1899-1910.
5. Johnson CN, Adkins NL, Georgel P,. Chromatin remodeling complexes: ATP-dependent machines in action. Biochem Cell Biol 2005; 83: 405-417.
6. Jenuwein T, Allis CD,. Translating the histone code. Science 2001; 293: 1074-1080.
7. Bird A., Perceptions of epigenetics. Nature 2007; 447: 396-398.
8. Chang CP, Bruneau BG,. Epigenetics and cardiovascular development. Annu Rev Physiol 2012; 74: 41-68.
9. Ohtani K, Vlachojannis GJ, Koyanagi M, et al., Epigenetic regulation of endothelial lineage committed genes in pro-angiogenic hematopoietic and endothelial progenitor cells. Circ Res 2011; 109: 1219-1229.
10. Shirodkar AV, Marsden PA,. Epigenetics in cardiovascular disease. Curr Opin Cardiol 2011; 26: 209-215.
11. Baccarelli A, Ghosh S,. Environmental exposures, epigenetics and cardiovascular disease. Curr Opin Clin Nutr Metab Care 2012; 15: 323-329.
12. Wang J, Yang X,. The function of miRNA in cardiac hypertrophy. Cell Mol Life Sci 2012; 69: 3561-3570.
13. Da Costa Martins PA, De Windt LJ,. MicroRNAs in control of cardiac hypertrophy. Cardiovasc Res 2012; 93: 563-572.
14. Zhu H, Fan GC,. Role of microRNAs in the reperfused myocardium towards post-infarct remodelling. Cardiovasc Res 2012; 94: 284-292.
15. Dorn GW, 2nd,. MicroRNAs in cardiac disease. Transl Res 2011; 157: 226-235.
16. Small EM, Frost RJ, Olson EN,. MicroRNAs add a new dimension to cardiovascular disease. Circulation 2010; 121: 1022-1032.
17. Latronico MV, Condorelli G,. MicroRNAs and cardiac pathology. Nat Rev Cardiol 2009; 6: 419-429.
18. Irons CE, Sei CA, Hidaka H, et al., Protein kinase C and calmodulin kinase are required for endothelin- stimulated atrial natriuretic factor secretion from primary atrial myocytes. J Biol Chem 1992; 267: 5211-5216.
19. Zhu W, Zou Y, Shiojima I, et al., Ca2+/calmodulin-dependent kinase II and calcineurin play critical roles in endothelin-1-induced cardiomyocyte hypertrophy. J Biol Chem 2000; 275: 15239-15245.
20. Spirito P, Autore C,. Management of hypertrophic cardiomyopathy. BMJ 2006; 332: 1251-1255.
21. Heineke J, Molkentin JD,. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006; 7: 589-600.
22. Clerk A, Cullingford TE, Fuller SJ, et al., Signaling pathways mediating cardiac myocyte gene expression in physiological and stress responses. J Cell Physiol 2007; 212: 311-322.
23. Berger SL,. Histone modifications in transcriptional regulation. Curr Opin Genet Dev 2002; 12: 142-148.
24. Grunstein M., Histone acetylation in chromatin structure and transcription. Nature 1997; 389: 349-352.
25. Vogelauer M, Wu J, Suka N, et al., Global histone acetylation and deacetylation in yeast. Nature 2000; 408: 495-498.
26. Turner BM,. Histone acetylation and an epigenetic code. Bioessays 2000; 22: 836-845.
27. Eberharter A, Becker PB,. Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep 2002; 3: 224-229.
28. Backs J, Olson EN,. Control of Cardiac Growth by Histone Acetylation/Deacetylation. Circulation Research 2006; 98: 15-24.
29. Yao TP, Oh SP, Fuchs M, et al., Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 1998; 93: 361-372.
30. Shikama N, Lutz W, Kretzschmar R, et al., Essential function of p300 acetyltransferase activity in heart, lung and small intestine formation. The EMBO Journal 2003; 22: 5175-5185.
31. Yanazume T, Hasegawa K, Morimoto T, et al., Cardiac p300 is involved in myocyte growth with decompensated heart failure. Mol Cell Biol 2003; 23: 3593-3606.
32. Gusterson RJ, Jazrawi E, Adcock IM, et al., The transcriptional co-activators CREB-binding protein (CBP) and p300 play a critical role in cardiac hypertrophy that is dependent on their histone acetyltransferase activity. J Biol Chem 2003; 278: 6838-6847.
33. Miyamoto S, Kawamura T, Morimoto T, et al., Histone acetyltransferase activity of p300 is required for the promotion of left ventricular remodeling after myocardial infarction in adult mice in vivo. Circulation 2006; 113: 679-690.
34. Mathiyalagan P, Chang L, Du XJ, et al., Cardiac ventricular chambers are epigenetically distinguishable. Cell Cycle 2010; 9: 612-617.
35. Heo K, Kim H, Choi SH, et al., FACT-mediated exchange of histone variant H2AX regulated by phosphorylation of H2AX and ADP-ribosylation of Spt16. Mol Cell 2008; 30: 86-97.
36. Haberland M, Montgomery RL, Olson EN,. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 2009; 10: 32-42.
37. Murray K,. The Occurrence Of Epsilon-N-Methyl Lysine In Histones. Biochemistry 1964; 3: 10-15.
38. Chen D, Ma H, Hong H, et al., Regulation of transcription by a protein methyltransferase. Science 1999; 284: 2174-2177.
39. Strahl BD, Ohba R, Cook RG, et al., Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena. Proc Natl Acad Sci U S A 1999; 96: 14967-14972.
40. van Weerd JH, Koshiba-Takeuchi K, Kwon C, et al., Epigenetic factors and cardiac development. Cardiovasc Res 2011; 91: 203-211.
41. Vallaster M, Vallaster CD, Wu SM,. Epigenetic mechanisms in cardiac development and disease. Acta Biochim Biophys Sin (Shanghai) 2012; 44: 92-102.
42. Stein AB, Jones TA, Herron TJ, et al., Loss of H3K4 methylation destabilizes gene expression patterns and physiological functions in adult murine cardiomyocytes. J Clin Invest 2011; 121: 2641-2650.
43. Pandya K, Kohro T, Mimura I, et al., Distribution of histone3 lysine 4 trimethylation at T3-responsive loci in the heart during reversible changes in gene expression. Gene Expr 2012; 15: 183-198.
44. Easley CA, Faison MO, Kirsch TL, et al., Laminin activates CaMK-II to stabilize nascent embryonic axons. Brain Res 2006; 1092: 59-68.
45. Lorenzen JM, Martino F, Thum T,. Epigenetic modifications in cardiovascular disease. Basic Res Cardiol 2012; 107: 245-245.
46. Nguyen AT, Xiao B, Neppl RL, et al., DOT1L regulates dystrophin expression and is critical for cardiac function. Genes Dev 2011; 25: 263-274.
47. Boyer LA, Plath K, Zeitlinger J, et al., Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 2006; 441: 349-353.
48. Roh TY, Cuddapah S, Cui K, et al., The genomic landscape of histone modifications in human T cells. Proc Natl Acad Sci U S A 2006; 103: 15782-15787.
49. Agger K, Cloos PA, Christensen J, et al., UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 2007; 449: 731-734.
50. Lee S, Lee JW, Lee SK,. UTX, a histone H3-lysine 27 demethylase, acts as a critical switch to activate the cardiac developmental program. Dev Cell 2012; 22: 25-37.
51. Zhang QJ, Chen HZ, Wang L, et al., The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice. J Clin Invest 2011; 121: 2447-2456.
52. Bernstein BE, Kamal M, Lindblad-Toh K, et al., Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 2005; 120: 169-181.
53. Kim TH, Barrera LO, Zheng M, et al., A high-resolution map of active promoters in the human genome. Nature 2005; 436: 876-880.
54. Bernstein BE, Mikkelsen TS, Xie X, et al., A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006; 125: 315-326.
55. Azuara V, Perry P, Sauer S, et al., Chromatin signatures of pluripotent cell lines. Nature cell biology 2006; 8: 532-538.
56. Kaneda R, Takada S, Yamashita Y, et al., Genome-wide histone methylation profile for heart failure. Genes Cells 2009; 14: 69-77.
57. Movassagh M, Choy MK, Knowles DA, et al., Distinct epigenomic features in end-stage failing human hearts. Circulation 2011; 124: 2411-2422.
58. Cheung P, Allis CD, Sassone-Corsi P,. Signaling to chromatin through histone modifications. Cell 2000; 103: 263-271.
59. Al-Nasser IA,. In vivo prevention of adriamycin cardiotoxicity by cyclosporin A or FK506. Toxicology 1998; 131: 175-181.
60. Bode AM, Dong Z,. Inducible covalent posttranslational modification of histone H3. Sci STKE 2005; 2005: re4.
61. Goto H, Tomono Y, Ajiro K, et al., Identification of a novel phosphorylation site on histone H3 coupled with mitotic chromosome condensation. J Biol Chem 1999; 274: 25543-25549.
62. Thomson S, Clayton AL, Hazzalin CA, et al., The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase. EMBO J 1999; 18: 4779-4793.
63. Yamamoto Y, Verma UN, Prajapati S, et al., Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression. Nature 2003; 423: 655-659.
64. Macdonald N, Welburn JP, Noble ME, et al., Molecular basis for the recognition of phosphorylated and phosphoacetylated histone h3 by 14-3-3. Mol Cell 2005; 20: 199-211.
65. Anversa P, Kajstura J,. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res 1998; 83: 1-14.
66. Kajstura J, Urbanek K, Perl S, et al., Cardiomyogenesis in the adult human heart. Circ Res 2010; 107: 305-315.
67. Cottage CT, Bailey B, Fischer KM, et al., Cardiac progenitor cell cycling stimulated by pim-1 kinase. Circ Res 2010; 106: 891-901.
68. Porrello ER, Mahmoud AI, Simpson E, et al., Transient regenerative potential of the neonatal mouse heart. Science 2011; 331: 1078-1080.
69. Liew CC, Sole MJ,. Studies of nuclear proteins in the heart of the cardiomyopathic Syrian hamster - phosphorylation of histones. J Mol Cell Cardiol 1978; 10: 847-855.
70. Hsu JY, Sun ZW, Li X, et al., Mitotic phosphorylation of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes. Cell 2000; 102: 279-291.
71. De Souza CP, Osmani AH, Wu LP, et al., Mitotic histone H3 phosphorylation by the NIMA kinase in Aspergillus nidulans. Cell 2000; 102: 293-302.
72. Sassone-Corsi P, Mizzen CA, Cheung P, et al., Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. Science 1999; 285: 886-891.
73. Anest V, Hanson JL, Cogswell PC, et al., A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. Nature 2003; 423: 659-663.
74. Zippo A, De Robertis A, Serafini R, et al., PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation. Nature cell biology 2007; 9: 932-944.
75. Baek SH,. When signaling kinases meet histones and histone modifiers in the nucleus. Mol Cell 2011; 42: 274-284.
76. Dawson MA, Bannister AJ, Gottgens B, et al., JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin. Nature 2009; 461: 819-822.
77. Bungard D, Fuerth BJ, Zeng PY, et al., Signaling kinase AMPK activates stress-promoted transcription via histone H2B phosphorylation. Science 2010; 329: 1201-1205.
78. Booz GW, Day JN, Baker KM,. Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure. J Mol Cell Cardiol 2002; 34: 1443-1453.
79. Karmazyn M, Purdham DM, Rajapurohitam V, et al., Leptin as a cardiac hypertrophic factor: a potential target for therapeutics. Trends Cardiovasc Med 2007; 17: 206-211.
80. Mahmoud SA KM, Little G.H, Bai Y,., An W,., Bers D,., Kedes L,. and, Poizat C,. Nuclear CaMKII Enhances Histone H3 Phosphorylation and Remodels Chromatin During Cardiac Hypertrophy. Nucleic Acids Res 2013; In Press.
81. Vega RB, Harrison BC, Meadows E, et al., Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol Cell Biol 2004; 24: 8374-8385.
82. Backs J, Song K, Bezprozvannaya S, et al., CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. The Journal of Clinical Investigation 2006: 1-12.
83. Little GH, Bai Y, Williams T, et al., Nuclear calcium/calmodulin- dependent protein kinase IIdelta preferentially transmits signals to histone deacetylase 4 in cardiac cells. J Biol Chem 2007; 282: 7219-7231.
84. Backs J, Backs T, Neef S, et al., The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc Natl Acad Sci U S A 2009; 106: 2342-2347.
85. Eom GH, Cho YK, Ko JH, et al., Casein kinase-2alpha1 induces hypertrophic response by phosphorylation of histone deacetylase 2 S394 and its activation in the heart. Circulation 2011; 123: 2392-2403.
86. Ogata N, Ueda K, Hayaishi O,. ADP-ribosylation of histone H2B. Identification of glutamic acid residue 2 as the modification site. J Biol Chem 1980; 255: 7610-7615.
87. Pillai JB, Gupta M, Rajamohan SB, et al., Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy. Am J Physiol Heart Circ Physiol 2006; 291: H1545-1553.
88. Bartha E, Solti I, Kereskai L, et al., PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats. Cardiovasc Res 2009; 83: 501-510.
89. Hang CT, Yang J, Han P, et al., Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature 2010; 466: 62-67.
90. Palfi A, Toth A, Kulcsar G, et al., The role of Akt and mitogen-activated protein kinase systems in the protective effect of poly(ADP-ribose) polymerase inhibition in Langendorff perfused and in isoproterenol-damaged rat hearts. J Pharmacol Exp Ther 2005; 315: 273-282.
91. Palfi A, Toth A, Hanto K, et al., PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway. J Mol Cell Cardiol 2006; 41: 149-159.
92. Robertson KD,. DNA methylation and human disease. Nat Rev Genet 2005; 6: 597-610.
93. Kangaspeska S, Stride B, Metivier R, et al., Transient cyclical methylation of promoter DNA. Nature 2008; 452: 112-115.
94. Handy DE, Castro R, Loscalzo J,. Epigenetic modifications: basic mechanisms and role in cardiovascular disease. Circulation 2011; 123: 2145-2156.
95. Movassagh M, Choy MK, Goddard M, et al., Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure. PLoS One 2010; 5: e8564.
96. Lee SH, Wolf PL, Escudero R, et al., Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 2000; 342: 626-633.
97. Eisen JA, Sweder KS, Hanawalt PC,. Evolution of the SNF2 family of proteins: subfamilies with distinct sequences and functions. Nucleic Acids Res 1995; 23: 2715-2723.
98. Winston F, Carlson M,. Yeast SNF/SWI transcriptional activators and the SPT/SIN chromatin connection. Trends Genet 1992; 8: 387-391.
99. Cote J, Quinn J, Workman JL, et al., Stimulation of GAL4 derivative binding to nucleosomal DNA by the yeast SWI/SNF complex. Science 1994; 265: 53-60.
100. Flaus A, Martin DMA, Barton GJ, et al., Identification of multiple distinct Snf2 subfamilies with conserved structural motifs. Nucleic Acids Res 2006; 34: 2887-2905.
101. Lessard J, Wu JI, Ranish JA, et al., An essential switch in subunit composition of a chromatin remodeling complex during neural development. Neuron 2007; 55: 201-215.
102. Lickert H, Takeuchi JK, Von Both I, et al., Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. Nature 2004; 432: 107-112.
103. Stankunas K, Hang CT, Tsun ZY, et al., Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis. Dev Cell 2008; 14: 298-311.
104. Jenni R, Rojas J, Oechslin E,. Isolated noncompaction of the myocardium. N Engl J Med 1999; 340: 966-967.
105. Fraga MF, Ballestar E, Paz MF, et al., Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 2005; 102: 10604-10609.
106. Bradshaw LA, Irimia A, Sims JA, et al., Biomagnetic characterization of spatiotemporal parameters of the gastric slow wave. Neurogastroenterol Motil 2006; 18: 619-631.
107. Javierre BM, Fernandez AF, Richter J, et al., Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome research 2010; 20: 170-179.
108. Turan N, Katari S, Coutifaris C, et al., Explaining inter-individual variability in phenotype: is epigenetics up to the challenge? Epigenetics 2010; 5: 16-19.